{
  "trial_id": "NCT01773616",
  "overall_assessment": "likely_ineligible",
  "inclusion": [],
  "exclusion": [
    {
      "criterion": "Obsolescence of >50% of the glomeruli or tubulointerstitial scarring of >50%",
      "label": "unknown"
    },
    {
      "criterion": "cellular crescents in >50% of the glomeruli",
      "label": "unknown"
    },
    {
      "criterion": "Severe 'critical' SLE flare defined as: BILAG 2004 A flare in CNS system",
      "label": "unknown"
    },
    {
      "criterion": "Pregnant or lactating. Woman who have child bearing potential must have two negative pregnancy test results with a sensitivity of \u2265 25 mIU/mL:",
      "label": "unknown"
    },
    {
      "criterion": "Patients not willing for their GP to be informed of their participation in this study",
      "label": "unknown"
    },
    {
      "criterion": "Patients should not be on or require maintenance steroids and should not have had more than 12 weeks of steroids in the period immediately preceding recruitment irrespective of dose",
      "label": "unknown"
    },
    {
      "criterion": "Patients that had received more than 2.0g of IV methyl prednisolone in the previous 4 weeks",
      "label": "unknown"
    },
    {
      "criterion": "Prior use within 12 months of screening visit of therapeutic monoclonal antibody, or B or T cell modulating 'biologic' use",
      "label": "unknown"
    },
    {
      "criterion": "Prior use within 6 months of the screening visit of Intravenous immunoglobulin / plasma exchange OR Cyclophosphamide",
      "label": "unknown"
    },
    {
      "criterion": "Active infections, including but not limited to the human immunodeficiency virus (HIV), and hepatitis B (including prior infection as judged by positive Hepatitis B core antibody) or Hepatitis C or tuberculosis",
      "label": "unknown"
    },
    {
      "criterion": "Receipt of a live-attenuated vaccine within 3 months of study enrolment",
      "label": "unknown"
    },
    {
      "criterion": "In the investigator's opinion, patients that are at high risk for infection (including but not limited to indwelling catheter, dysphagia with aspiration, decubitus ulcer, history of prior aspiration pneumonia or recurrent severe urinary tract infection)",
      "label": "unknown"
    },
    {
      "criterion": "Prior history of invasive fungal infections",
      "label": "unknown"
    },
    {
      "criterion": "History of any cancer",
      "label": "unknown"
    }
  ],
  "notes": "Patient is a 22yo F with systemic mastocytosis, presenting with flushing and tachycardia. She has had multiple flares in the past month while on steroid taper, which is new for her.",
  "_meta": {
    "topic_id": "10",
    "trial_id": "NCT01773616",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}